Report Detail

Request for Sample of this report

Pharma & Healthcare Global Amifostine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4709744
    • |
  • 17 June, 2026
    • |
  • Global
    • |
  • 96 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Amifostine market size was valued at US$ 527 million in 2025 and is forecast to a readjusted size of US$ 886 million by 2032 with a CAGR of 5.9% during review period.
Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol. In 2025, global Amifostine production reached approximately 4.68 M unit.
The amifostine market is primarily shaped by its role as a cytoprotective agent used alongside chemotherapy and radiotherapy to reduce toxic side effects such as xerostomia and myelosuppression. Its clinical application is most notable in cancer care, particularly for head and neck cancers, though off-label exploration in other areas has also contributed to steady demand. The growing incidence of cancer worldwide, coupled with the rising adoption of supportive care therapies, supports market expansion. Additionally, increasing awareness of treatment-related quality-of-life issues and hospital protocols emphasizing patient safety have sustained the relevance of amifostine in oncology.
At the same time, the market faces headwinds from high treatment costs, limited availability in some regions, and the emergence of alternative protective agents or treatment regimens with fewer side effects. Patent expiries and the entry of generics have led to greater price competition, particularly in emerging markets where affordability drives uptake. Opportunities lie in expanding access through generics, advancing formulations to reduce adverse reactions such as hypotension and nausea, and integrating amifostine into broader supportive oncology care strategies. Overall, while niche compared to mainstream oncology drugs, the amifostine market remains stable, supported by its unique protective benefits in cancer treatment.
This report is a detailed and comprehensive analysis for global Amifostine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Amifostine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
Global Amifostine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
Global Amifostine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
Global Amifostine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Amifostine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Amifostine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Legacy Pharma / Ethyol, Sun Pharma, Taj Pharmaceuticals, Luye Pharma, Merro Pharmaceutical, Kaifeng Mingren Pharma, Shenzhen Zifu Pharma, Sichuan Huiyu Pharma / Huiyu Haiyue, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Amifostine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
400mg/Dose
500mg/Dose
Market segment by Channel
Direct Sales
Distribution
Market segment by Technology
Original Drug
Generic Drug
Market segment by Application
Advanced Ovarian Cancer
Head and Neck Tumors
Others
Major players covered
Legacy Pharma / Ethyol
Sun Pharma
Taj Pharmaceuticals
Luye Pharma
Merro Pharmaceutical
Kaifeng Mingren Pharma
Shenzhen Zifu Pharma
Sichuan Huiyu Pharma / Huiyu Haiyue
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Amifostine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Amifostine, with price, sales quantity, revenue, and global market share of Amifostine from 2021 to 2026.
Chapter 3, the Amifostine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Amifostine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Amifostine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Amifostine.
Chapter 14 and 15, to describe Amifostine sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Amifostine Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 400mg/Dose
    • 1.3.3 500mg/Dose
  • 1.4 Market Analysis by Channel
    • 1.4.1 Overview: Global Amifostine Consumption Value by Channel: 2021 Versus 2025 Versus 2032
    • 1.4.2 Direct Sales
    • 1.4.3 Distribution
  • 1.5 Market Analysis by Technology
    • 1.5.1 Overview: Global Amifostine Consumption Value by Technology: 2021 Versus 2025 Versus 2032
    • 1.5.2 Original Drug
    • 1.5.3 Generic Drug
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global Amifostine Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Advanced Ovarian Cancer
    • 1.6.3 Head and Neck Tumors
    • 1.6.4 Others
  • 1.7 Global Amifostine Market Size & Forecast
    • 1.7.1 Global Amifostine Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global Amifostine Sales Quantity (2021-2032)
    • 1.7.3 Global Amifostine Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Legacy Pharma / Ethyol
    • 2.1.1 Legacy Pharma / Ethyol Details
    • 2.1.2 Legacy Pharma / Ethyol Major Business
    • 2.1.3 Legacy Pharma / Ethyol Amifostine Product and Services
    • 2.1.4 Legacy Pharma / Ethyol Amifostine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Legacy Pharma / Ethyol Recent Developments/Updates
  • 2.2 Sun Pharma
    • 2.2.1 Sun Pharma Details
    • 2.2.2 Sun Pharma Major Business
    • 2.2.3 Sun Pharma Amifostine Product and Services
    • 2.2.4 Sun Pharma Amifostine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Sun Pharma Recent Developments/Updates
  • 2.3 Taj Pharmaceuticals
    • 2.3.1 Taj Pharmaceuticals Details
    • 2.3.2 Taj Pharmaceuticals Major Business
    • 2.3.3 Taj Pharmaceuticals Amifostine Product and Services
    • 2.3.4 Taj Pharmaceuticals Amifostine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Taj Pharmaceuticals Recent Developments/Updates
  • 2.4 Luye Pharma
    • 2.4.1 Luye Pharma Details
    • 2.4.2 Luye Pharma Major Business
    • 2.4.3 Luye Pharma Amifostine Product and Services
    • 2.4.4 Luye Pharma Amifostine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Luye Pharma Recent Developments/Updates
  • 2.5 Merro Pharmaceutical
    • 2.5.1 Merro Pharmaceutical Details
    • 2.5.2 Merro Pharmaceutical Major Business
    • 2.5.3 Merro Pharmaceutical Amifostine Product and Services
    • 2.5.4 Merro Pharmaceutical Amifostine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Merro Pharmaceutical Recent Developments/Updates
  • 2.6 Kaifeng Mingren Pharma
    • 2.6.1 Kaifeng Mingren Pharma Details
    • 2.6.2 Kaifeng Mingren Pharma Major Business
    • 2.6.3 Kaifeng Mingren Pharma Amifostine Product and Services
    • 2.6.4 Kaifeng Mingren Pharma Amifostine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Kaifeng Mingren Pharma Recent Developments/Updates
  • 2.7 Shenzhen Zifu Pharma
    • 2.7.1 Shenzhen Zifu Pharma Details
    • 2.7.2 Shenzhen Zifu Pharma Major Business
    • 2.7.3 Shenzhen Zifu Pharma Amifostine Product and Services
    • 2.7.4 Shenzhen Zifu Pharma Amifostine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Shenzhen Zifu Pharma Recent Developments/Updates
  • 2.8 Sichuan Huiyu Pharma / Huiyu Haiyue
    • 2.8.1 Sichuan Huiyu Pharma / Huiyu Haiyue Details
    • 2.8.2 Sichuan Huiyu Pharma / Huiyu Haiyue Major Business
    • 2.8.3 Sichuan Huiyu Pharma / Huiyu Haiyue Amifostine Product and Services
    • 2.8.4 Sichuan Huiyu Pharma / Huiyu Haiyue Amifostine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Sichuan Huiyu Pharma / Huiyu Haiyue Recent Developments/Updates

3 Competitive Environment: Amifostine by Manufacturer

  • 3.1 Global Amifostine Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Amifostine Revenue by Manufacturer (2021-2026)
  • 3.3 Global Amifostine Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Amifostine by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Amifostine Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Amifostine Manufacturer Market Share in 2025
  • 3.5 Amifostine Market: Overall Company Footprint Analysis
    • 3.5.1 Amifostine Market: Region Footprint
    • 3.5.2 Amifostine Market: Company Product Type Footprint
    • 3.5.3 Amifostine Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Amifostine Market Size by Region
    • 4.1.1 Global Amifostine Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Amifostine Consumption Value by Region (2021-2032)
    • 4.1.3 Global Amifostine Average Price by Region (2021-2032)
  • 4.2 North America Amifostine Consumption Value (2021-2032)
  • 4.3 Europe Amifostine Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Amifostine Consumption Value (2021-2032)
  • 4.5 South America Amifostine Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Amifostine Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Amifostine Sales Quantity by Type (2021-2032)
  • 5.2 Global Amifostine Consumption Value by Type (2021-2032)
  • 5.3 Global Amifostine Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Amifostine Sales Quantity by Application (2021-2032)
  • 6.2 Global Amifostine Consumption Value by Application (2021-2032)
  • 6.3 Global Amifostine Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Amifostine Sales Quantity by Type (2021-2032)
  • 7.2 North America Amifostine Sales Quantity by Application (2021-2032)
  • 7.3 North America Amifostine Market Size by Country
    • 7.3.1 North America Amifostine Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Amifostine Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Amifostine Sales Quantity by Type (2021-2032)
  • 8.2 Europe Amifostine Sales Quantity by Application (2021-2032)
  • 8.3 Europe Amifostine Market Size by Country
    • 8.3.1 Europe Amifostine Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Amifostine Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Amifostine Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Amifostine Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Amifostine Market Size by Region
    • 9.3.1 Asia-Pacific Amifostine Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Amifostine Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Amifostine Sales Quantity by Type (2021-2032)
  • 10.2 South America Amifostine Sales Quantity by Application (2021-2032)
  • 10.3 South America Amifostine Market Size by Country
    • 10.3.1 South America Amifostine Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Amifostine Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Amifostine Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Amifostine Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Amifostine Market Size by Country
    • 11.3.1 Middle East & Africa Amifostine Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Amifostine Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Amifostine Market Drivers
  • 12.2 Amifostine Market Restraints
  • 12.3 Amifostine Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Amifostine and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Amifostine
  • 13.3 Amifostine Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Amifostine Typical Distributors
  • 14.3 Amifostine Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Amifostine. Industry analysis & Market Report on Amifostine is a syndicated market report, published as Global Amifostine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Amifostine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo